Please login to the form below

Not currently logged in
Email:
Password:

Astellas Pharma

This page shows the latest Astellas Pharma news and features for those working in and with pharma, biotech and healthcare.

China first market to approve AZ’s kidney drug roxadustat

China first market to approve AZ’s kidney drug roxadustat

AZ and FibroGen have rights to roxadustat in the US, China and other world markets, while Astellas Pharma will sell the drug in Europe and Japan.

Latest news

More from news
Approximately 1 fully matching, plus 123 partially matching documents found.

Latest Intelligence

  • Getting multichannel marketing right Getting multichannel marketing right

    How the atomisation of communication is challenging and benefiting pharma. The habits and priorities of the purchasers, prescribers and users of medicines are changing rapidly. ... They’re not going to want it in a month, much less six months,” Chad

  • The good, the bad and the ugly The good, the bad and the ugly

    AstraZeneca, Takeda, Astellas Pharma, Novo Nordisk and Recordati take up the final five positions, though only two - Takeda (3.9%) and Astellas (9.3%) - recorded growth. ... The data this article was based on is available in full online:

  • Case study: Action on Fistula Case study: Action on Fistula

    Client:Astellas Pharma EMEA Limited. Agency:Forster Communications. Campaign:Action on Fistula. Timescale:. Action on Fistula, launched in May 2014, is an innovative partnership between Astellas Pharma EMEA Limited and the ... Astellas’ investment in

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    Yasuo Sakae, vice president of corporate strategy and planning at Astellas Pharma Europe, told PME that the company’s regulatory team for the Europe, Middle East and Africa (EMEA) region is ... globally, as well as the presence of world-class

  • Deal Watch July 2016 Deal Watch July 2016

    $225m. $36m. LEO Pharma. AstraZeneca. $1, 115m. $115m. Astellas. Cytokinetics. $100m. ... In at numbers 2, 3 and 4 are the LEO-AstraZeneca deal with an upfront of $115m, Astellas-Cytokinetics at $95m and Almirall-Sun Pharma at $50m (see below).

More from intelligence
Approximately 1 fully matching, plus 21 partially matching documents found.

Latest appointments

  • Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands

    Taylor joins the agency from Astellas, where she was senior director of corporate communications, EMEA. ... run those very departments in global pharma companies and we therefore completely understand the challenges they face.

  • Astellas strengthens US and Canadian leadership team Astellas strengthens US and Canadian leadership team

    Astellas has promoted Steve Sabus (pictured right) to general manager of Astellas Pharma Canada, effective from 1 April this year. ... needs.”. Sabus joined Astellas in 2007 and has over 25 years’ experience in the pharmaceutical industry.

  • Astellas promotes Anthony Fiordaliso to VP, Americas finance Astellas promotes Anthony Fiordaliso to VP, Americas finance

    He first joined the pharma firm in 2010 from Schering-Plough. Astellas has promoted Anthony Fiodaliso to VP, Americas finance to oversee areas such as managerial reporting and budgeting, financial planning ... In his new role Fiordaliso will report

  • Dendreon appoints new R&D lead Dendreon appoints new R&D lead

    Joining from Astellas Pharma, Dr Brown most recently served as senior medical director of oncology, where he led US medical strategy for the prostate cancer drug Xtandi (enzalutamide).

  • Astellas appoints new senior VP Astellas appoints new senior VP

    Astellas.”. “I’m confident she will make an immediate and positive impact on both the team in the Americas, as well as the patients and partners we serve.”. ... She has also received multiple awards for leadership and innovation through her career

More from appointments
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics